With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust Analysis

[at noodls] – ACC.13 Presentation Features Unprecedented Data on Nearly 5,000 Patients, Including All Comers, from Global RESOLUTE Clinical Program SAN FRANCISCO — March 11, 2013 — Cardiologists at ACC.13 … more

View todays social media effects on MDT

View the latest stocks trending across Twitter. Click to view dashboard

See who Medtronic is hiring next, click here to view